agilon health (NYSE:AGL) Price Target Raised to $3.15

agilon health (NYSE:AGL) had its price objective lifted by Sanford C. Bernstein from $2.50 to $3.15 in a report published on Wednesday morning,Benzinga reports. Sanford C. Bernstein currently has a market perform rating on the stock.

Several other analysts also recently issued reports on the company. TD Cowen reduced their price objective on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $3.00 price target on shares of agilon health in a research note on Tuesday, November 19th. Needham & Company LLC initiated coverage on shares of agilon health in a report on Friday, January 10th. They set a “hold” rating for the company. Bank of America downgraded shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective on the stock. in a research note on Wednesday, October 2nd. Finally, Stifel Nicolaus lowered their target price on shares of agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a research note on Tuesday, November 12th. Two equities research analysts have rated the stock with a sell rating, fourteen have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $4.03.

agilon health Price Performance

Shares of NYSE AGL opened at $3.12 on Wednesday. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The company’s 50-day moving average price is $2.07 and its 200 day moving average price is $3.67. agilon health has a 52 week low of $1.50 and a 52 week high of $7.73. The stock has a market cap of $1.28 billion, a price-to-earnings ratio of -3.31 and a beta of 0.53.

agilon health (NYSE:AGL) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion for the quarter, compared to analysts’ expectations of $1.47 billion. During the same period last year, the business earned ($0.06) earnings per share. As a group, research analysts forecast that agilon health will post -0.59 earnings per share for the current fiscal year.

Insider Transactions at agilon health

In other agilon health news, Director Karen Mcloughlin bought 25,000 shares of the business’s stock in a transaction dated Friday, December 13th. The shares were acquired at an average price of $2.20 per share, with a total value of $55,000.00. Following the purchase, the director now owns 73,166 shares in the company, valued at approximately $160,965.20. The trade was a 51.90 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Diana Mckenzie purchased 12,500 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The shares were acquired at an average cost of $2.28 per share, with a total value of $28,500.00. Following the completion of the transaction, the director now owns 51,319 shares in the company, valued at $117,007.32. This trade represents a 32.20 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders bought 90,000 shares of company stock worth $198,100. 3.20% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the stock. Rhumbline Advisers grew its stake in shares of agilon health by 24.3% in the second quarter. Rhumbline Advisers now owns 433,019 shares of the company’s stock valued at $2,832,000 after buying an additional 84,573 shares in the last quarter. XTX Topco Ltd purchased a new position in agilon health in the 2nd quarter worth approximately $211,000. Simplify Asset Management Inc. acquired a new stake in agilon health in the second quarter valued at approximately $659,000. Ensign Peak Advisors Inc raised its stake in shares of agilon health by 43.5% during the second quarter. Ensign Peak Advisors Inc now owns 140,937 shares of the company’s stock valued at $922,000 after purchasing an additional 42,750 shares during the period. Finally, Bank of Montreal Can acquired a new position in shares of agilon health during the second quarter worth $404,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.